Tempest Therapeutics, Inc. Accrued Liabilities
Tempest Therapeutics, Inc. (TPST) had Accrued Liabilities of $7.57 million as of 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent · last filed 2016-02-26
- 2015-12-31: Accrued Liabilities $7.57M.
- 2014-12-31: Accrued Liabilities $7.65M.
| Period end | Accrued Liabilities |
|---|---|
| 2015-12-31 | $7.57M 10-K · filed 2016-02-26 |
| 2014-12-31 | $7.65M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |